Response monitoring in late-stage multiple myeloma
Response monitoring in late-stage multiple myeloma Heinz Ludwig, MD, Wilhelminen Cancer Research Institute, Wilhelminenspital, Vienna, Austria, gives an overview of his presentation on response monitoring in multiple myeloma. Prof. Ludwig describes the use of correlation between tumor cell mass and paraprotein production in patients with early-stage myeloma to monitor response to therapy, and highlights the […]
Read More